M
Mehpare Ozkan
Researcher at Bahçeşehir University
Publications - 3
Citations - 596
Mehpare Ozkan is an academic researcher from Bahçeşehir University. The author has contributed to research in topics: Neuraminidase & Odds ratio. The author has an hindex of 3, co-authored 3 publications receiving 510 citations.
Papers
More filters
Journal ArticleDOI
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
Stella G. Muthuri,Sudhir Venkatesan,Puja R. Myles,Jo Leonardi-Bee,Tarig Saleh Al Khuwaitir,Adbullah Al Mamun,Ashish P Anovadiya,Eduardo Azziz-Baumgartner,Clarisa Báez,Matteo Bassetti,Bojana Beović,Barbara Bertisch,Isabelle Bonmarin,Robert Booy,Víctor Hugo Borja-Aburto,Heinz Burgmann,Bin Cao,Jordi Carratalà,Justin T Denholm,Samuel R. Dominguez,Péricles Almeida Delfino Duarte,Gal Dubnov-Raz,Marcela Echavarria,Sergio Fanella,Zhancheng Gao,Patrick Gérardin,Maddalena Giannella,Sophie Gubbels,Jethro Herberg,A. Iglesias,Peter Höger,Xiaoyun Hu,Quazi Tarikul Islam,Mirela Foresti Jiménez,Amr Kandeel,Gerben Keijzers,Hossein Khalili,Marian Knight,Koichiro Kudo,Gabriela Kusznierz,Ilija Kuzman,Arthur M C Kwan,Idriss Lahlou Amine,Eduard Langenegger,Kamran Bagheri Lankarani,Yee-Sin Leo,Rita Linko,Pei Liu,Faris Madanat,Elga Mayo-Montero,Allison McGeer,Ziad A. Memish,Gökhan Metan,Auksė Mickiene,Dragan Mikić,Kristin G.-I. Mohn,Kristin G.-I. Mohn,Ahmadreza Moradi,Ahmadreza Moradi,Pagbajabyn Nymadawa,Maria E. Oliva,Mehpare Ozkan,Dhruv Parekh,Mical Paul,Fernando P. Polack,Barbara Rath,Alejandro Rodríguez,Elena B. Sarrouf,Anna C. Seale,Anna C. Seale,Bunyamin Sertogullarindan,Marilda M. Siqueira,Joanna Skręt-Magierło,Frank P. Stephan,Ewa Talarek,Julian W. Tang,Julian W. Tang,Kelvin K. W. To,Antoni Torres,Selda Hançerli Törün,Dat Tran,Timothy M. Uyeki,Annelies van Zwol,Wendy Vaudry,Tjasa Vidmar,Renata T. C. Yokota,Paul Zarogoulidis,Jonathan S. Nguyen-Van-Tam +87 more
TL;DR: There was an increase in the mortality hazard rate with each day's delay in initiation of treatment up to day 5 as compared with treatment initiated within 2 days of symptom onset, and early treatment versus no treatment was also associated with a reduction in mortality risk.
Journal ArticleDOI
Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: An individual participant data meta-analysis
Stella G. Muthuri,Sudhir Venkatesan,Puja R. Myles,Jo Leonardi-Bee,Wei Shen Lim,Abdullah Al Mamun,Ashish P Anovadiya,Wildo Navegantes de Araújo,Eduardo Azziz-Baumgartner,Clarisa Báez,C. Bantar,Mazen M. Barhoush,Matteo Bassetti,Bojana Beović,Roland Bingisser,Isabelle Bonmarin,Víctor Hugo Borja-Aburto,Bin Cao,Jordi Carratalà,María R. Cuezzo,Justin T Denholm,Samuel R. Dominguez,Péricles Almeida Delfino Duarte,Gal Dubnov-Raz,Marcela Echavarria,Sergio Fanella,James Fraser,Zhancheng Gao,Patrick Gérardin,Maddalena Giannella,Sophie Gubbels,Jethro Herberg,A. Iglesias,Peter H. Hoeger,Matthias Hoffmann,Xiaoyun Hu,Quazi Tarikul Islam,Mirela Foresti Jiménez,Amr Kandeel,Gerben Keijzers,Hossein Khalili,Gulam Khandaker,Marian Knight,Gabriela Kusznierz,Ilija Kuzman,Arthur M C Kwan,Idriss Lahlou Amine,Eduard Langenegger,Kamran Bagheri Lankarani,Yee Sin Leo,Rita Linko,Pei Liu,Faris Madanat,Toshie Manabe,Elga Mayo-Montero,Allison McGeer,Ziad A. Memish,Gökhan Metan,Dragan Mikić,Kristin G.-I. Mohn,Kristin G.-I. Mohn,Ahmadreza Moradi,Ahmadreza Moradi,Pagbajabyn Nymadawa,Bülent Özbay,Mehpare Ozkan,Dhruv Parekh,Mical Paul,Wolfgang Poeppl,Fernando P. Polack,Barbara Rath,Alejandro Rodríguez,Marilda M. Siqueira,Joanna Skręt-Magierło,Ewa Talarek,Julian W. Tang,Julian W. Tang,Antoni Torres,Selda Hançerli Törün,Dat Tran,Timothy M. Uyeki,Annelies van Zwol,Wendy Vaudry,Daiva Velyvyte,Tjasa Vidmar,Paul Zarogoulidis,Jonathan S. Nguyen-Van-Tam +86 more
TL;DR: The objective was to investigate the association between NAI treatment and IRP incidence and outcomes in patients hospitalised with A(H1N1)pdm09 virus infection.
Journal ArticleDOI
Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.
Sudhir Venkatesan,Puja R. Myles,Kirsty J. Bolton,Stella G. Muthuri,Al Khuwaitir T,Ashish P Anovadiya,Azziz-Baumgartner E,Tahar Bajjou,Matteo Bassetti,Bojana Beović,Barbara Bertisch,Isabelle Bonmarin,Robert Booy,Víctor Hugo Borja-Aburto,Heinz Burgmann,Bin Cao,Jordi Carratalà,Chinbayar T,Catia Cilloniz,Justin T Denholm,Dominguez,Duarte Pad,Gal Dubnov-Raz,Sergio Fanella,Zhancheng Gao,Patrick Gérardin,Maddalena Giannella,Sophie Gubbels,Jethro Herberg,Higuera Iglesias Al,Peter H. Hoeger,Xiaoyun Hu,Quazi Tarikul Islam,Mirela Foresti Jiménez,Gerben Keijzers,Hossein Khalili,Gabriela Kusznierz,Ilija Kuzman,Eduard Langenegger,Kamran Bagheri Lankarani,Yee-Sin Leo,Romina Libster,Rita Linko,Faris Madanat,Maltezos E,Adbullah Al Mamun,Toshie Manabe,Gökhan Metan,Auksė Mickiene,Dragan Mikić,Mohn Kgi,Maria E. Oliva,Mehpare Ozkan,Dhruv Parekh,Mical Paul,Barbara Rath,S.A.M. Refaey,Rodríguez Ah,Bunyamin Sertogullarindan,Joanna Skręt-Magierło,Ayper Somer,Ewa Talarek,Julian W. Tang,Kelvin K. W. To,Tran D,Timothy M. Uyeki,Wendy Vaudry,Tjasa Vidmar,Paul Zarogoulidis,Jonathan S. Nguyen-Van-Tam +69 more
TL;DR: When patients hospitalized with influenza are treated with NAIs, treatment initiated on admission, regardless of time since symptom onset, is associated with a reduced LoS, compared with later or no initiation of treatment.